Mentor: Dr. Roger Blair
College of Liberal Arts and Sciences
While I was helping Dr. Blair with his Competition Policy in Health Care Markets book, I noticed something strange in the pharmaceutical market. This is when Dr. Blair and I started to explore reverse payments. Doing undergraduate research is a great experience because as a young student, I get to explore policy and propose new solutions to real world problems.
- Environmental Policy
- Competitive Markets
- University Scholars Program (2017-2018)
- Florida Academic Scholars (2015-Present)
Florida Women in Business
Gators Going Green
Hobbies and Interests
Settlements of Patent Disputes in the Aftermath of Actavis
The Hatch-Waxman Act expedites the ability for generics to enter markets; however, pioneer drug companies have been suing generic companies for infringing on their patents. In the end, the two companies generally settle with the pioneer company paying the generic company. I am researching these payments and seeing whether or not they are per se illegal under the Sherman Act.